Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, WI 53706, USA.
Department of Microbiology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Nucleic Acids Res. 2024 Apr 12;52(6):3199-3212. doi: 10.1093/nar/gkae133.
Productive infections by RNA viruses require faithful replication of the entire genome. Yet many RNA viruses also produce deletion-containing viral genomes (DelVGs), aberrant replication products with large internal deletions. DelVGs interfere with the replication of wild-type virus and their presence in patients is associated with better clinical outcomes. The DelVG RNA itself is hypothesized to confer this interfering activity. DelVGs antagonize replication by out-competing the full-length genome and triggering innate immune responses. Here, we identify an additionally inhibitory mechanism mediated by a new class of viral proteins encoded by DelVGs. We identified hundreds of cryptic viral proteins translated from DelVGs. These DelVG-encoded proteins (DPRs) include canonical viral proteins with large internal deletions, as well as proteins with novel C-termini translated from alternative reading frames. Many DPRs retain functional domains shared with their full-length counterparts, suggesting they may have activity during infection. Mechanistic studies of DPRs derived from the influenza virus protein PB2 showed that they poison replication of wild-type virus by acting as dominant-negative inhibitors of the viral polymerase. These findings reveal that DelVGs have a dual inhibitory mechanism, acting at both the RNA and protein level. They further show that DPRs have the potential to dramatically expand the functional proteomes of diverse RNA viruses.
生产性 RNA 病毒感染需要忠实复制整个基因组。然而,许多 RNA 病毒也会产生含有缺失的病毒基因组(DelVGs),这是一种带有大量内部缺失的异常复制产物。DelVGs 会干扰野生型病毒的复制,其在患者体内的存在与更好的临床结果相关。DelVG RNA 本身被假设赋予了这种干扰活性。DelVGs 通过与全长基因组竞争和触发先天免疫反应来拮抗复制。在这里,我们确定了一种由 DelVGs 编码的新类病毒蛋白介导的额外抑制机制。我们从 DelVGs 中鉴定了数百种隐匿的病毒蛋白。这些 DelVG 编码的蛋白(DPRs)包括具有大内部缺失的典型病毒蛋白,以及从不同阅读框翻译而来的具有新型 C 末端的蛋白。许多 DPR 保留了与其全长对应物共享的功能域,表明它们在感染过程中可能具有活性。来自流感病毒蛋白 PB2 的 DPR 的机制研究表明,它们通过作为病毒聚合酶的显性负抑制剂来毒害野生型病毒的复制。这些发现表明 DelVGs 具有双重抑制机制,在 RNA 和蛋白质水平上均起作用。它们进一步表明,DPR 有可能显著扩展不同 RNA 病毒的功能蛋白质组。